TMX Newsfile Biotechnology News Releases

Defence Therapeutics Provides Updates on Sharing Agreement

Fri, 04 Sep 2026 18:00:00 -0400

Montreal, Quebec--(Newsfile Corp. - September 4, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular drug-delivery company, is pleased to provide an update on its sharing agreement dated March 6, 2026 (the "Sharing Agreement") with Sorbie Bornholm LP ("SBLP") previously described in the Company's news releases of March 9 and February 27, 2026.On March 6, 2026, the Company completed a...

MustGrow Announces Officer Appointment and Grant of DSUs

Fri, 04 Sep 2026 07:00:00 -0400

Saskatoon, Saskatchewan--(Newsfile Corp. - September 4, 2026) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") today announced the appointment of Tyler Reinheimer, CPA, as Director, Finance of the Company and that the board of directors of the Company has authorized and approved the grant of a total of 1,126,954 deferred share units of the Company ("DSUs") to directors (excluding the Company's Chief Excutive Officer and Chief Operating Officer) and...

Nextleaf Solutions Reports Fiscal Q3 2026 Financial Results

Thu, 03 Sep 2026 17:01:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - September 3, 2026) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf" or the "Company"), a multi-patented Canadian cannabis processor, released its financial results for the third quarter ended June 30, 2026.The quarter reflected sequential improvement in net revenue and a significant reduction in excise taxes, supported by a broadened product mix including non-excisable bulk sales and tolling services. Net revenue...

BioHarvest Sciences Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE)

Thu, 03 Sep 2026 07:00:00 -0400

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 3, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development today announced its intention to offer its ordinary shares on the Tel Aviv Stock Exchange (TASE) and to become dual-listed for trade on both the Nasdaq and TASE markets. BioHarvest expects its shares to begin trading on the TASE on September 8, 2026.Dr Zaki Rakib,...

Restart Life Sciences Reports Second Quarter 2026 Results Highlighted by 146% Sequential Revenue Growth

Thu, 03 Sep 2026 06:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - September 3, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce its financial and operating results for the three and six months ended June 30, 2026. All financial figures are expressed in Canadian dollars ($) unless otherwise noted, are prepared in accordance with International Financial Reporting Standards (IFRS), and are unaudited.In the second quarter of 2026,...

Envoy Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14th-16th

Wed, 02 Sep 2026 08:30:00 -0400

White Bear Lake, Minnesota--(Newsfile Corp. - September 2, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions, today announced that Brent Lucas, Envoy Medical's Chief Executive Officer, will present at the H.C. Wainwright 28th Annual Global Investment Conference, on September 14-16, 2026 at the Lotte New York Palace Hotel in New York City.H.C. Wainwright Conference Presentation...

OS Therapies Provides OST-HER2 Metastatic Osteosarcoma Program Update and Announces Upcoming Conference Attendance

Wed, 02 Sep 2026 07:20:00 -0400

Management will participate at Jefferies Global Healthcare Conference, H.C. Wainwright Global Investment Conference, ROTH Healthcare Opportunities Conference Management and business development advisors will attend BioJapan Interim 3-year overall survival data, U.S. FDA Type C Statistical Methods meeting and U.K. MHRA Statistical Methods Scientific Advice Meeting expected in September 2026RMAT and Rolling Review decisions expected to follow U.S. FDA meetingFinal 3-year overall survival data,...

Biosenta Enters into Memorandum of Understanding with Dynamic Facility Services for TRUE(TM) Pilot Program

Tue, 01 Sep 2026 17:13:00 -0400

Calgary, Alberta--(Newsfile Corp. - September 1, 2026) - Biosenta Inc. (CSE: ZRO) ("Biosenta" or the "Company") announces that it has entered into a Memorandum of Understanding ("MOU") with Dynamic Facility Services Ltd. ("Dynamic"), a British Columbia-based commercial cleaning and facility services company, to conduct a pilot program evaluating the use of Biosenta's TRUE™ disinfectant within Dynamic's commercial cleaning operations.Under the MOU, Dynamic will conduct a pilot project to evaluate...

Marvel Biosciences Announces Grant of Deferred Share Units

Tue, 01 Sep 2026 17:01:00 -0400

Calgary, Alberta--(Newsfile Corp. - September 1, 2026) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), announces the award of 50,001 deferred share units ("DSUs") to Marvel's three independent directors, in lieu of cash payment for directors' fees.The DSUs will all vest on September 1, 2027. Vested DSUs shall be settled upon the directors' separation from service from the Company and expire 365 days...

TempraMed Signs Letter of Intent with CPO Greece for Exclusive Distribution of VIVI Products in Greece

Tue, 01 Sep 2026 06:45:00 -0400

Highlights:LOI with CPO Greece includes exclusive distribution of VIVI Cap™ and VIVI Epi™ throughout Greece, subject to a definitive agreement.Proposed exclusivity is conditional on minimum annual purchase obligations, with combined purchases required to increase by at least 20% year over year to maintain exclusivity.Transfer pricing and the first-year minimum unit commitment will be negotiated and established in the definitive distribution agreement.CPO Greece brings an established pharmacy...